Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence Cher

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|April 15, 2004
BCNU as second line therapy for recurrent high-grade glioma previously treated with TemozolomideMark A Rosenthal, David L Ashley, Lawrence Cher
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|April 2, 2002
Treatment of high risk or recurrent meningiomas with hydroxyureaMark A Rosenthal, David L Ashley, Lawrence Cher
Neuro-Oncology Practice|May 14, 2026
Treatment outcomes and toxicity of carboplatin after relapse in patients with gliomaJennifer Yao, Oliver Nilsen, Lawrence Cher, et al.
Neuro-Oncology|February 13, 2010
Neurolymphomatosis: diagnosis, management, and outcomes in patients treated with rituximabHui K Gan, Arun Azad, Lawrence Cher, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|March 6, 2014
Mistaken identity: granular cell astrocytoma masquerading as histiocytosis of the central nervous systemRobert N Campbell, Mun Sem Liew, Hui K Gan, et al.
Asia-Pacific Journal of Clinical Oncology|March 3, 2022
The systemic management of central nervous system metastases and leptomeningeal disease from advanced lung, melanoma, and breast cancer with molecular drivers: An Australian perspectiveClare Senko, Ashray Gunjur, Adithya Balasubramanian, et al.
Internal Medicine Journal|June 21, 2018
Clinical correlates of severe thrombocytopenia from temozolomide in glioblastoma patientsSurein Arulananda, James Lynam, Mun Sem Liew, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|October 30, 2009
Spinal drop metastasis from grade I skull base chondrosarcomaNick D P Hall, Gavin Fabinyi, Shahid M Gul, et al.
Journal of Neuro-Oncology|August 6, 2022
Poor correlation between preclinical and patient efficacy data for tumor targeted monotherapies in glioblastoma: the results of a systematic reviewAshray Gunjur, Adithya Balasubramanian, Umbreen Hafeez, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|October 16, 2018
A single-institution prospective evaluation of a neuro-oncology multidisciplinary team meetingMalaka Ameratunga, Dorothea Miller, Wayne Ng, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|April 15, 2004
BCNU as second line therapy for recurrent high-grade glioma previously treated with TemozolomideMark A Rosenthal, David L Ashley, Lawrence Cher
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|April 2, 2002
Treatment of high risk or recurrent meningiomas with hydroxyureaMark A Rosenthal, David L Ashley, Lawrence Cher
Neuro-Oncology Practice|May 14, 2026
Treatment outcomes and toxicity of carboplatin after relapse in patients with gliomaJennifer Yao, Oliver Nilsen, Lawrence Cher, et al.
Neuro-Oncology|February 13, 2010
Neurolymphomatosis: diagnosis, management, and outcomes in patients treated with rituximabHui K Gan, Arun Azad, Lawrence Cher, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|March 6, 2014
Mistaken identity: granular cell astrocytoma masquerading as histiocytosis of the central nervous systemRobert N Campbell, Mun Sem Liew, Hui K Gan, et al.
Asia-Pacific Journal of Clinical Oncology|March 3, 2022
The systemic management of central nervous system metastases and leptomeningeal disease from advanced lung, melanoma, and breast cancer with molecular drivers: An Australian perspectiveClare Senko, Ashray Gunjur, Adithya Balasubramanian, et al.
Internal Medicine Journal|June 21, 2018
Clinical correlates of severe thrombocytopenia from temozolomide in glioblastoma patientsSurein Arulananda, James Lynam, Mun Sem Liew, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|October 30, 2009
Spinal drop metastasis from grade I skull base chondrosarcomaNick D P Hall, Gavin Fabinyi, Shahid M Gul, et al.
Journal of Neuro-Oncology|August 6, 2022
Poor correlation between preclinical and patient efficacy data for tumor targeted monotherapies in glioblastoma: the results of a systematic reviewAshray Gunjur, Adithya Balasubramanian, Umbreen Hafeez, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|October 16, 2018
A single-institution prospective evaluation of a neuro-oncology multidisciplinary team meetingMalaka Ameratunga, Dorothea Miller, Wayne Ng, et al.
Pageof 4